Summit X, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Summit X, LLC

$423 Million
Q3 2024

A detailed history of Summit X, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Summit X, LLC holds 288 shares of REGN stock, worth $205,171. This represents 0.07% of its overall portfolio holdings.

Number of Shares

288

Previous 293 1.71%

Holding current value

$205,171

Previous $307,000 1.63%

% of portfolio

0.07%

Previous 0.07%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$1024.09 - $1201.76 $5,120 - $6,008	-5 Reduced 1.71%	288 $302,000
Q2 2024 Aug 13, 2024	BUY	$883.2 - $1071.19 $4,416 - $5,355	5 Added 1.74%	293 $307,000
Q1 2024 May 08, 2024	SELL	$902.69 - $993.35 $492,868 - $542,369	-546 Reduced 65.47%	288 $277,000
Q4 2023 Feb 08, 2024	SELL	$775.18 - $881.7 $13,953 - $15,870	-18 Reduced 2.11%	834 $732,000
Q3 2023 Nov 03, 2023	SELL	$692.45 - $844.37 $6,232 - $7,599	-9 Reduced 1.05%	852 $701,000
Q2 2023 Aug 09, 2023	SELL	$700.03 - $830.35 $51,102 - $60,615	-73 Reduced 7.82%	861 $618,000
Q1 2023 May 10, 2023	SELL	$680.49 - $826.97 $8,165 - $9,923	-12 Reduced 1.27%	934 $767,000
Q4 2022 Feb 02, 2023	SELL	$705.89 - $766.39 $705 - $766	-1 Reduced 0.11%	946 $682,000
Q3 2022 Nov 01, 2022	BUY	$573.97 - $724.32 $573 - $724	1 Added 0.11%	947 $654,000
Q2 2022 Aug 12, 2022	SELL	$548.35 - $738.84 $49,899 - $67,234	-91 Reduced 8.78%	946 $558,000
Q1 2022 May 05, 2022	SELL	$595.12 - $698.43 $435,627 - $511,250	-732 Reduced 41.38%	1,037 $720,000
Q4 2021 Jan 19, 2022	SELL	$543.48 - $670.97 $34,782 - $42,942	-64 Reduced 3.49%	1,769 $1.12 Million
Q3 2021 Oct 19, 2021	SELL	$574.03 - $680.96 $297,921 - $353,418	-519 Reduced 22.07%	1,833 $1.11 Million
Q2 2021 Jul 16, 2021	BUY	$472.8 - $558.54 $9,456 - $11,170	20 Added 0.86%	2,352 $1.31 Million
Q1 2021 May 10, 2021	BUY	$446.73 - $548.2 $283,673 - $348,107	635 Added 37.42%	2,332 $1.1 Million
Q4 2020 Jan 29, 2021	BUY	$478.3 - $607.98 $443,384 - $563,597	927 Added 120.39%	1,697 $810,000
Q3 2020 Nov 12, 2020	BUY	$544.75 - $658.21 $14,163 - $17,113	26 Added 3.49%	770 $39.7 Million
Q2 2020 Aug 13, 2020	SELL	$493.32 - $643.92 $108,037 - $141,018	-219 Reduced 22.74%	744 $464,000
Q1 2020 May 13, 2020	BUY	$336.18 - $494.43 $1,680 - $2,472	5 Added 0.52%	963 $465,000
Q4 2019 Jan 23, 2020	SELL	$274.13 - $376.51 $38,926 - $53,464	-142 Reduced 12.91%	958 $361,000
Q3 2019 Oct 15, 2019	BUY	$273.46 - $318.39 $14,766 - $17,193	54 Added 5.16%	1,100 $310,000
Q2 2019 Aug 13, 2019	BUY	$299.6 - $414.82 $56,624 - $78,400	189 Added 22.05%	1,046 $309,000
Q1 2019 May 13, 2019	BUY	$372.08 - $439.57 $318,872 - $376,711	857 New	857 $352,000

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.4B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit X, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit X, LLC with notifications on news.

Account